Glp 1 And Gip Receptor Agonist Drugs
-
{
- All
- News
-
Beyond GLP-1: New 5-In-1 Compound More Effective Than Semaglutide For Diabetes And Weight Loss
This innovative compound is known as a 'quintuple agonist' because it combines the power of GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists with lanifibranor.
-
Is Erectile Dysfunction A Side Effect Of Taking Weight-Loss Drugs? New Trial Results Say Yes
A new study links GLP-1 drugs, used for diabetes and weight loss, to a higher risk of erectile dysfunction.
-
New Study Finds Diabetes, Weight Loss Drugs May Lower Rheumatoid Arthritis Flares
A study presented at ACR Convergence 2025 suggests that GLP 1 receptor agonists reduce flares and systemic inflammation in Rheumatoid Arthritis (RA) patients.
-
Beyond GLP-1: New 5-In-1 Compound More Effective Than Semaglutide For Diabetes And Weight Loss
This innovative compound is known as a 'quintuple agonist' because it combines the power of GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists with lanifibranor.
-
Is Erectile Dysfunction A Side Effect Of Taking Weight-Loss Drugs? New Trial Results Say Yes
A new study links GLP-1 drugs, used for diabetes and weight loss, to a higher risk of erectile dysfunction.
-
New Study Finds Diabetes, Weight Loss Drugs May Lower Rheumatoid Arthritis Flares
A study presented at ACR Convergence 2025 suggests that GLP 1 receptor agonists reduce flares and systemic inflammation in Rheumatoid Arthritis (RA) patients.
